Experienced in IgG4-Related Disease

Marek A. Ruchala

Przybyszewskiego St. 49, 
Poznan, WP, PL 
Experienced in IgG4-Related Disease
Przybyszewskiego St. 49, 
Poznan, WP, PL 
OverviewLocationsClinical Research

Overview

Marek Ruchala practices in Poznan, Poland. Mr. Ruchala is rated as an Experienced expert by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Hyperthyroidism, Graves Disease, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 431 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of IgG4-Related Disease.

Gender
Male

Locations

Przybyszewskiego St. 49, Poznan, WP 60355, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
Enrollment Status: Terminated
Publish Date: July 06, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

431 Total Publications

Hypogonadism and Hypothyroidism Masquerading as Frailty and Cognitive Decline: Complete Reversal After Hormone Replacement.
Hypogonadism and Hypothyroidism Masquerading as Frailty and Cognitive Decline: Complete Reversal After Hormone Replacement.
Journal: QJM : monthly journal of the Association of Physicians
Published: October 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ruchala's expertise for a condition
ConditionClose
View All 16 Distinguished Conditions
View All 27 Advanced Conditions
View All 91 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile